Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • AthenaHQ Reviews & Ratings
    17 Ratings
    Company Website
  • Revaly Reviews & Ratings
    7 Ratings
    Company Website
  • wp2print Reviews & Ratings
    23 Ratings
    Company Website
  • Pipedrive Reviews & Ratings
    9,564 Ratings
    Company Website
  • Ango Hub Reviews & Ratings
    15 Ratings
    Company Website
  • ScriptSure Reviews & Ratings
    30 Ratings
    Company Website
  • Docket Reviews & Ratings
    58 Ratings
    Company Website
  • Semrush Reviews & Ratings
    6,115 Ratings
    Company Website
  • SciSure Reviews & Ratings
    295 Ratings
    Company Website
  • JDisc Discovery Reviews & Ratings
    27 Ratings
    Company Website

What is Iktos?

Makya emerges as a groundbreaking user-focused SaaS platform specifically tailored for AI-driven de novo drug design, with a particular focus on Multi-Parametric Optimization (MPO). This cutting-edge tool enables users to generate original and easily synthesizable compounds through a multi-objective framework, achieving unparalleled speed, efficiency, and diversity in results. Featuring a variety of generative algorithms that cater to different phases of drug development—from hit discovery to lead optimization—Makya includes a fine-tuning generator for identifying optimal solutions within your defined chemical space, a novelty generator aimed at uncovering new ideas for re-scaffolding and hit identification, and a forward generator that assembles a specialized library of compounds ready for synthesis using commercially accessible starting materials. The platform's latest addition, the Makya 3D module, markedly enhances both the user experience and scientific functionality. With an extensive toolkit of 3D modeling capabilities for both ligand-based and structure-based methodologies, Makya 3D facilitates the computation of 3D scores that can be effortlessly integrated to steer compound generation within the platform. This comprehensive integration not only refines the design workflow but also provides researchers with profound insights into their molecular architectures, ultimately transforming the drug discovery landscape. As researchers increasingly seek innovative solutions, Makya stands at the forefront, revolutionizing the way compounds are designed and developed.

What is 3decision?

3decision® is a cutting-edge cloud-hosted platform designed to serve as a centralized hub for protein structures, emphasizing effective management of structural data and advanced analytics to accelerate the identification of small molecules and biologics through structure-guided drug design. This platform integrates and standardizes both experimental and computational protein structures from well-known public repositories like RCSB PDB and AlphaFoldDB, as well as proprietary data, while accommodating various file formats including PDBx/mmCIF and ModelCIF. Such a comprehensive strategy ensures easy accessibility to a diverse array of structural data, encompassing X-Ray, NMR, cryo-EM, and modeled structures, thereby fostering collaboration and boosting scientific research efforts. Beyond basic storage capabilities, 3decision® enhances its entries with important metadata and sequence information, detailing aspects such as protein-ligand interactions, antibody information, and binding site features. Its sophisticated analytical tools empower researchers to pinpoint potential druggable sites, assess off-target activities, and compare binding sites, thus transforming vast structural datasets into actionable insights. The platform's cloud-based functionality not only promotes effortless collaboration among research teams but also positions itself as an indispensable asset for driving forward drug discovery projects, ultimately contributing to the advancement of therapeutic solutions. Additionally, its user-friendly interface and robust support for data integration make it a favorite among scientists aiming for innovative breakthroughs in the field.

Media

Media

No images available

Integrations Supported

Amazon Web Services (AWS)
Google Cloud Platform
Microsoft Azure
Python

Integrations Supported

Amazon Web Services (AWS)
Google Cloud Platform
Microsoft Azure
Python

API Availability

Has API

API Availability

Has API

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

Iktos

Company Location

France

Company Website

iktos.ai/makya/

Company Facts

Organization Name

Discngine

Date Founded

2004

Company Location

France

Company Website

www.discngine.com

Categories and Features

Categories and Features

Popular Alternatives

SILCS Reviews & Ratings

SILCS

SilcsBio

Popular Alternatives

SILCS Reviews & Ratings

SILCS

SilcsBio
Aurora Drug Discovery Reviews & Ratings

Aurora Drug Discovery

Aurora Fine Chemicals
BioNeMo Reviews & Ratings

BioNeMo

NVIDIA
AIDDISON Reviews & Ratings

AIDDISON

Merck KGaA
AlphaFold Reviews & Ratings

AlphaFold

DeepMind